BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28337616)

  • 1. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.
    Atmaca M; Gulhan B; Korkmaz E; Inozu M; Soylemezoglu O; Candan C; Bayazıt AK; Elmacı AM; Parmaksiz G; Duzova A; Besbas N; Topaloglu R; Ozaltin F
    Pediatr Nephrol; 2017 Aug; 32(8):1369-1375. PubMed ID: 28337616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation.
    Atmaca M; Gülhan B; Atayar E; Bayazıt AK; Candan C; Arıcı M; Topaloğlu R; Özaltın F
    Turk J Pediatr; 2019; 61(5):657-663. PubMed ID: 32104996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
    Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
    J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COQ8B nephropathy: Early detection and optimal treatment.
    Song X; Fang X; Tang X; Cao Q; Zhai Y; Chen J; Liu J; Zhang Z; Xiang T; Qian Y; Wu B; Wang H; Zhou W; Liu C; Shen Q; Xu H; Rao J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1360. PubMed ID: 32543055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome.
    Wang F; Zhang Y; Mao J; Yu Z; Yi Z; Yu L; Sun J; Wei X; Ding F; Zhang H; Xiao H; Yao Y; Tan W; Lovric S; Ding J; Hildebrandt F
    Pediatr Nephrol; 2017 Jul; 32(7):1181-1192. PubMed ID: 28204945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.
    Park E; Kang HG; Choi YH; Lee KB; Moon KC; Jeong HJ; Nagata M; Cheong HI
    Pediatr Nephrol; 2017 Sep; 32(9):1547-1554. PubMed ID: 28405841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset of ADCK4 glomerulopathy with renal failure: a case report.
    Lolin K; Chiodini BD; Hennaut E; Adams B; Dahan K; Ismaili K
    BMC Med Genet; 2017 Mar; 18(1):28. PubMed ID: 28298181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset COQ8B (ADCK4) glomerulopathy in a child with isolated proteinuria: a case report and literature review.
    Zhai SB; Zhang L; Sun BC; Zhang Y; Ma QS
    BMC Nephrol; 2020 Sep; 21(1):406. PubMed ID: 32957916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.
    Korkmaz E; Lipska-Ziętkiewicz BS; Boyer O; Gribouval O; Fourrage C; Tabatabaei M; Schnaidt S; Gucer S; Kaymaz F; Arici M; Dinckan A; Mir S; Bayazit AK; Emre S; Balat A; Rees L; Shroff R; Bergmann C; Mourani C; Antignac C; Ozaltin F; Schaefer F;
    J Am Soc Nephrol; 2016 Jan; 27(1):63-8. PubMed ID: 25967120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term nephrotic syndrome recurrence risk of kidney transplantation in two siblings with ADCK4-associated glomerulopathy.
    Wang S; Zhao F; Li L; Yu Z
    Pediatr Transplant; 2022 Feb; 26(1):e14143. PubMed ID: 34605136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.
    Drovandi S; Lipska-Ziętkiewicz BS; Ozaltin F; Emma F; Gulhan B; Boyer O; Trautmann A; Xu H; Shen Q; Rao J; Riedhammer KM; Heemann U; Hoefele J; Stenton SL; Tsygin AN; Ng KH; Fomina S; Benetti E; Aurelle M; Prikhodina L; Schreuder MF; Tabatabaeifar M; Jankowski M; Baiko S; Mao J; Feng C; Liu C; Sun S; Deng F; Wang X; Clavé S; Stańczyk M; Bałasz-Chmielewska I; Fila M; Durkan AM; Levart TK; Dursun I; Esfandiar N; Haas D; Bjerre A; Anarat A; Benz MR; Talebi S; Hooman N; Ariceta G; ; ; ; Schaefer F
    Kidney Int; 2022 Sep; 102(3):604-612. PubMed ID: 35643375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel ADCK4 mutation in a Chinese family with ADCK4-Associated glomerulopathy.
    Yang J; Yang Y; Hu Z
    Biochem Biophys Res Commun; 2018 Nov; 506(3):444-449. PubMed ID: 30352687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADCK4 "reenergizes" nephrotic syndrome.
    Malaga-Dieguez L; Susztak K
    J Clin Invest; 2013 Dec; 123(12):4996-9. PubMed ID: 24270414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment.
    Widmeier E; Yu S; Nag A; Chung YW; Nakayama M; Fernández-Del-Río L; Hugo H; Schapiro D; Buerger F; Choi WI; Helmstädter M; Kim JW; Ryu JH; Lee MG; Clarke CF; Hildebrandt F; Gee HY
    J Am Soc Nephrol; 2020 Jun; 31(6):1191-1211. PubMed ID: 32381600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of WT1 nephropathy and follow up in a Chinese multicenter cohort.
    Sun S; Xu L; Bi Y; Wang J; Zhang Z; Tang X; Cao Q; Zhai Y; Chen J; Fang X; Liu J; Fang Y; Xiang T; Qian Y; Wu B; Wang H; Zhou W; Shen J; Dong K; Liu X; Zheng B; Zhang A; Wang X; Wu Y; Ma D; Shen Q; Rao J; Xu H
    Eur J Med Genet; 2020 Nov; 63(11):104047. PubMed ID: 32891756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
    Preston R; Stuart HM; Lennon R
    Pediatr Nephrol; 2019 Feb; 34(2):195-210. PubMed ID: 29181713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coenzyme Q(10) treatment for one child with COQ6 gene mutation induced nephrotic syndrome and literature review].
    Cao Q; Li GM; Xu H; Shen Q; Sun L; Fang XY; Liu HM; Guo W; Zhai YH; Wu BB
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):135-138. PubMed ID: 28173653
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
    Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.
    Feng C; Wang Q; Wang J; Liu F; Shen H; Fu H; Mao J
    Medicine (Baltimore); 2017 Nov; 96(47):e8880. PubMed ID: 29382012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.